ProPharma Group acquires Diamond Pharma Services
ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Diamond Pharma Services. As an award-winning team of regulatory experts with deep subject matter knowledge for handling challenging therapeutic classes, Diamond’s team will help accelerate the value ProPharma Group brings in delivering regulatory science to companies working on cutting-edge therapeutics with ProPharma Group’s ATMPs/Cell and Gene Therapy Center of Excellence.